Baby Track

Safer Pregnancy

RAISING

$1,000,000

In exchange for

30%
Share on facebook
Share on twitter
Share on linkedin

Industry

PHARMA

Company size

2-5

Patent

NO

Location

Israel

Languages

Hebrew, English

Overview

The company is developing an at-home blood test device to assist millions of women worldwide undergoing fertility treatments. 

A small app-based product to make the entire process accessible. 

Get tested without leaving your home and get an answer in real-time with 99% accuracy.

The Vision

Simplifying the pregnancy process for every woman in the world.

The Product

A smartphone-sized device that allows women to draw a drop of blood onto a stick using a needle.

The sample is then inserted into the device, which uses special UV rays to identify whether there are specific proteins indicating pregnancy.

Once the result is identified, it is displayed in the app linked to the device, and simultaneously sending the data to the client’s physician and medical center administering treatments.

The device is currently in the process of patent registration and is proprietary to the company. 

The Team

Matan Leker

CEO

Criminal and civil advocate with 10+ years of experience in marketing, branding, and corporate business development; high tech developer.

Ayala Kyster

VP & Co-Founder

Senior software engineer at the Hebrew University of Jerusalem; 6+ years of management experience; extensive experience developing software, websites and applications.

The Problem & Solution

During fertility treatments, patients must physically visit the medical center to take blood tests. Some cases require dozens of blood samples.

Patient – The frequency of such tests makes the patient’s daily routine challenging and an already complex procedure even more difficult: transportation, absence from work, time consumption, stressful wait for results.

Medical Staff – The unnecessary overloading of HMOs and blood labs directly impacts efficiency, prolongs lab result waiting times, and requires significant human resources.

The Market

We are initially targeting the American and European markets – but the global potential is huge.

The global IVF market is expected to reach 36.39 billion USD by 2026, with a 10.1% CAGR

An estimated 15% of couples have trouble conceiving (UCLA health 2020)

Estimates suggest that globally,  186 million women live with infertility (WHO – DHS 2004)

Every country worldwide has women with a “child wish” suffering from infertility issues.

Competition

Our solution is unique and does not exist in the market.

The Opportunity

There is no other company that provides home blood tests for the IVF procedure – we are the pioneers of home tests for IVF procedures.

Purpose of Equity

$1,000,000 for prototype development.

A D D M Y S T A R T U P
Qilindo Logo | the Startup Network
Interested in Baby Track?

Contact them directly.